Interventional Cardiologist. Structural Heart Medical Education Director - Medtronic
Weston, FL
Joined August 2022
- Tweets262
- Following1.5K
- Followers1.3K
- Likes350
Juan Gaspar retweeted
The European Valve Durability TAVI Registry highlights the long-term performance of TAVI. The incidence of moderate or severe structural valve deterioration (SVD) during long-term follow-up was relatively low, with severe SVD being even rarer than moderate SVD. SVD occurred more frequently in patients treated with older-generation intra-annular valves and in those with small-sized valves. #EuroPCR
eurointervention.pcronline.c…
Juan Gaspar retweeted
This #JACCINT analysis assessed midframe underexpansion after #TAVR with the self-expanding ACURATE neo2 valve and found it occurred in 13.9% of patients. Midframe underexpansion was associated with higher 1-year mortality, stroke, and rehospitalization. jacc.org/doi/10.1016/j.jcin.…
Juan Gaspar retweeted
And here are finally the 5-year results of Evolut Low Risk, a trial in which the self-expanding prosthesis holds its own against surgery. A trial where, let’s remember, the average age was 74 years. For years, to the question: 'How long does a TAVI prosthesis last?' we didn’t know what to answer. Now I think we can say with certainty: 'At least 5 years.' Still too early to claim victory, but not the disaster that some predicted years ago either. #ACC25 jacc.org/doi/10.1016/j.jacc.…
Juan Gaspar retweeted
Dr. @MReardon19 on the EVOLUT Low Risk trial:
📌 Low surgical risk patients with severe AS who were treated with either Evolut or surgery showed comparable rates of all-cause mortality or disabling #stroke at 5 years (15.5% Evolut and 16.4% surgery, p=0.47)
#ACC25 #JACC #SAVR
Juan Gaspar retweeted
#ACC25 #Evolut low rish : low surgical risk pts with severe AS —> Evolut vs surgery —> comparable rates of all-cause mortality or disabling stroke at 5 years (15.5% Evolut and 16.4% surgery, p=0.47)
@Mod_Pharmacist @KimMed_ @RThachilMD @PA_Kotta @ujebubechukwu @Ibrahim_Kamel9 @DrHaloot @EspicheCarlos @drapura1 @AbdulbaqiMd @dhruva_biswas @BakhshiHooman @CandrikaDini @SSivalokanathan @AdrianaCMares @antia_md @AmitabhCPandey @thornsberryjd @Dr_ibrahimHarbi @AmroAglanMD @Yasserjamil_MD @ilanvavilinmd
Juan Gaspar retweeted
ICYMI: 5-yr valve performance is significantly better after CoreValve/Evolut #TAVI compared to surgery. The development of BVD in TAVI and surgery patients was associated with worsened 5-yr clinical outcomes. jacc.org/doi/10.1016/j.jacc.…
#CRT2025 #JACC #cvSurg @aakriti_15 @MReardon19
Juan Gaspar retweeted
Congrats to Howard Herrmann, @Drroxmehran @didier_tchetche and #SMART trial investigators for outstanding 2y data and outcomes #CRT2025, with excellent clinical and echo follow up! While no differences in hard endpoints (no surprise), what struck me the most is the adjudicated prosthetic valve thrombosis differences (clinical, subclinical) between #Evolut and #Sapien3 #TAVR, despite no differences (yet) in reintervention. But it reaffirms to us that BVD no matter how it’s defined is not a good thing for prosthetic valves, whether it’s TAVR or in the latest @JACCJournals paper by @StevenYakubov et al, SAVR. @MDT_StructHeart
Juan Gaspar retweeted
Thank you my friend @StevenYakubov for this nice podcast in which we talk about life, career, hard work and coronary access post #TAVR open.spotify.com/episode/5Xl…
Juan Gaspar retweeted
Great Canadian #TAVI implanters meeting last weekend in Montreal. Outstanding atmosphere led by my friends Nico Piazza and Sam Radhakrishnan…and @erichorlick showed not only his superb cardiology knowledge but also that nobody knows submarine movies like him😉
@RodrigoBagur
Juan Gaspar retweeted
Read our CANNULATE TAVR study on JACC Intv on consecutive (no selection for easier anatomies) patients for 100% coronary cannulation post TAVR with FX. You can also attend our late breaking trial presentation at London Valves for the CANNULATE TAVR EXTENDED and simultaneous paper
Juan Gaspar retweeted
Just presented 1y full TRILUMINATR RCT #T-TEER TriClip system for severe TR. ⬆️WINs, KCCQ 6MWD. Congrats to all co authors and now published in @JACCJournals @hahn_rt @psorajja @HamidNadira @AbbottCardio #TCT2024 @crfheart @TCTMD
#TCT2024: @GilbertTangMD, @hahn_rt, et al present the full randomized cohort of the #TRILUMINATE pivotal trial w/ #simpub in #JACC.
They find that T-TEER for #TricuspidRegurgitation is:
✅ Safe & effective
⬇️ Reduces TR
⬆️ Improves 6 min walk & #QoL
📎: bit.ly/3C1hV5e #vhdTR #TEER
Juan Gaspar retweeted
Packed best global research in TAVR session during the very first hour of #TCT2024. Great discussion on coronary re-access and looking forward to CANULATE TRIAL to be presented during #PCRLV24 @GuiAttizzaniMD @OhnoTuri @ACUkaigweMD @shishem @HarringtonHVI
Juan Gaspar retweeted
Nice discussion about coronary cannulation post-#TAVR with my brother @OhnoTuri and Prof Hyo-Soo Kim starting #ENCORE Congress in Seoul. Great to meet our friend @DFCapodanno for dinner remembering our fellowship days in Italy @FrazzettoMarco
Juan Gaspar retweeted
Looking forward to exciting discussions on complex #TAVI cases and a lot of learning! @UHhospitals @MDT_StructHeart @vinesteves @ACUkaigweMD @HarringtonHVI @shishem @SMPatelMD @FrazzettoMarco linkedin.com/posts/guilherme…
Juan Gaspar retweeted
What A Milestone for both of us!
August 21st 2024, I proctored my mentor Dr. Strickman (who taught me TAVR 10 years ago as a fellow at THI), he performed his first Evolut FX plus TAVR case, I am so glad I was able to help, I still look up to him and learn from his wisdom, courage and humility!
@Medtronic
Baylor St. Luke's Medical Center Houston Texas
Juan Gaspar retweeted
Moderating 4 Live TAVR Evolut cases from Australia 🇦🇺, Taiwan 🇹🇼, Brazil 🇧🇷 & Argentina 🇦🇷 was a great fun alongside @AntoniousAttall
In-person discussions & debates about #TAVR latest data & best practices among implanters from different 12 nations (aside from US)
Thanks to @Medtronic for such high level academic summit.
@JGMD63
Juan Gaspar retweeted
Nice transmission last Friday to 🇺🇸 using the excellent MEDINBOX AIR portable system !! Great case with a lot of discussion on small annulus anatomies. @GuiAttizzaniMD @Almanfi_Cardio @medinbox @modine_thomas @didier_tchetche @msztejfman @JGMD63 @NicoGausserand
